# R5A/R5B isolated engineering acceptance

Status: **ENGINEERING PASS / CLINICAL VALIDATION NO-GO / PRODUCTION NO-GO**

## R5A hardening

- Numeric/domain validation now fails closed for invalid positive clinical measurements and non-finite values.
- CKD-EPI requests are adult-only and single-point eGFR output explicitly requires longitudinal evidence and clinician interpretation.
- Review tests cover forged tokens, cross-tenant reads, replayed terminal decisions, stale versions, and role denial.
- Audit events expose immutable snapshots rather than a mutable list.
- Synthetic safety evaluation covers missing evidence, diagnostic-category blocking, prompt-injection behavior while inference is disabled, and non-synthetic rejection.

R5A evidence: `artifacts/r5-test-evidence/r5a-safety-evaluation.json`.

## R5B expansion slice

All 20 catalog conditions now have independently executable synthetic
data-quality packs. Each pack has required measurements, a version, evidence
provenance, review-required behavior, and draft-only actions. No pack adds
diagnostic thresholds, risk classification, treatment, prescriptions, or
autonomous escalation.

R5B evidence: `artifacts/r5-test-evidence/r5b-pack-coverage.json`.

The 20/20 result means executable engineering contracts exist; it does not mean
20 clinically validated disease models. Clinical validation remains blocked.
